Stay updated on Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays the full study record for NCT03222856, replacing the prior error page and including the study overview, eligibility criteria, and locations.
    Difference
    64%
    Check dated 2026-08-15T15:12:05.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5 instead of Revision: v3.6.4, reflecting a small version update.
    Difference
    0.0%
    Check dated 2026-08-08T10:48:54.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is now displayed, replacing Revision: v3.6.3. This update seems to be a site version update rather than a substantive change to the study information.
    Difference
    0.0%
    Check dated 2026-07-25T05:27:57.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now displayed, replacing Revision: v3.6.2. This indicates a version update for the page/system rather than a content addition or removal.
    Difference
    0.0%
    Check dated 2026-07-03T21:46:38.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.6.2 replaces v3.6.0 on the page, representing a minor update to the page's version tag. It does not change the displayed study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-06-26T19:38:36.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page adds sections for No longer looking for participants, How to Read a Study Record, Common Questions, and How to Join a Study, and adjusts the Intervention/Treatment heading; it also removes the old Intervention / Treatment heading and old Revision label while adding Revision: v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T12:25:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.